Michael Egholm insider trades
Open-market stock purchases and sales by Michael Egholm, President & CEO at Standard Biotools Inc, from SEC Form 4 filings since Jan 10, 2013.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 20, 2026 | LAB Standard Biotools Inc | Sold (not open market) | $97.6K |
| Apr 6, 2026 | LAB Standard Biotools Inc | Sold (not open market) | $86.3K |
| Apr 6, 2026 | LAB Standard Biotools Inc | Bought (not open market) | — |
| Mar 20, 2026 | LAB Standard Biotools Inc | Bought (not open market) | — |
| Mar 20, 2026 | LAB Standard Biotools Inc | Bought (not open market) | — |
| Feb 23, 2026 | LAB Standard Biotools Inc | Sold (not open market) | $76K |
| Nov 20, 2025 | LAB Standard Biotools Inc | Sold (not open market) | $81.3K |